{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:05:46Z","timestamp":1788588346057,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Barbour Watson Trust"},{"DOI":"10.13039\/501100000593","name":"Society for Reproduction and Fertility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P011535\/1"],"award-info":[{"award-number":["MR\/P011535\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maternal exposure to increased steroid hormones, including estrogens, androgens or glucocorticoids during pregnancy results in chronic conditions in offspring that manifest in adulthood. Little is known about effects of progesterone administration in early pregnancy on fetal development. We hypothesised that maternal early pregnancy progesterone supplementation would increase fetal progesterone, affect progesterone target tissues in the developing fetal reproductive system and be metabolised to other bioactive steroids in the fetus. We investigated the effects of progesterone treatment during early pregnancy on maternal and fetal plasma progesterone concentrations, transcript abundance in the fetal pituitary and testes and circulating steroids, at day 75 gestation, using a clinically realistic ovine model. Endogenous progesterone concentrations were lower in male than female fetuses. Maternal progesterone administration increased male, but not female, fetal progesterone concentrations, also increasing circulating 11-dehydrocorticosterone in male fetuses. Maternal progesterone administration altered fetal pituitary and testicular function in ovine male fetuses. This suggests that there may be fetal sex specific effects of the use of progesterone in early pregnancy, and highlights that progesterone supplementation should be used only when there is clear evidence of efficacy and for as limited time as necessary.<\/jats:p>","DOI":"10.1038\/s41598-020-78976-x","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T11:04:43Z","timestamp":1607943883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Early pregnancy maternal progesterone administration alters pituitary and testis function and steroid profile in male fetuses"],"prefix":"10.1038","volume":"10","author":[{"given":"Katarzyna J.","family":"Siemienowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Mare\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Nio-Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick T.","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Colin","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"78976_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.reprotox.2016.07.011","volume":"68","author":"S-M Ho","year":"2017","unstructured":"Ho, S.-M. et al. Environmental factors, epigenetics, and developmental origin of reproductive disorders. Reprod. Toxicol. 68, 85\u2013104 (2017).","journal-title":"Reprod. Toxicol."},{"key":"78976_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jsbmb.2011.08.007","volume":"127","author":"TT Schug","year":"2011","unstructured":"Schug, T. T., Janesick, A., Blumberg, B. & Heindel, J. J. Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 127, 204\u2013215 (2011).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"78976_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/er.2009-0002","volume":"30","author":"E Diamanti-Kandarakis","year":"2009","unstructured":"Diamanti-Kandarakis, E. et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 30, 293\u2013342 (2009).","journal-title":"Endocr. Rev."},{"key":"78976_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/bdrc.21035","volume":"99","author":"CE Reed","year":"2013","unstructured":"Reed, C. E. & Fenton, S. E. Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects. Birth Defects Res. (Part C) 99, 134\u2013146 (2013).","journal-title":"Birth Defects Res. (Part C)"},{"key":"78976_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/216083a0","volume":"216","author":"I Gal","year":"1967","unstructured":"Gal, I., Kirman, B. & Stern, J. Hormonal pregnancy tests and congenital malformation. Nature 216, 83\u201383 (1967).","journal-title":"Nature"},{"key":"78976_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.rbms.2018.09.003","volume":"6","author":"J Olszynko-Gryn","year":"2018","unstructured":"Olszynko-Gryn, J., Bj\u00f8rvik, E., We\u00dfel, M., J\u00fclich, S. & Jean, C. A historical argument for regulatory failure in the case of Primodos and other hormone pregnancy tests. Reprod. Biomed. Soc. Online 6, 34\u201344 (2018).","journal-title":"Reprod. Biomed. Soc. Online"},{"key":"78976_CR7","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.12688\/f1000research.16758.1","volume":"7","author":"C Heneghan","year":"2018","unstructured":"Heneghan, C. et al. Oral hormone pregnancy tests and the risks of congenital malformations: a systematic review and meta-analysis. F1000Res 7, 1725 (2018).","journal-title":"F1000Res"},{"key":"78976_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1210\/en.2011-1607","volume":"153","author":"K Hogg","year":"2012","unstructured":"Hogg, K. et al. Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology 153, 450\u2013461 (2012).","journal-title":"Endocrinology"},{"key":"78976_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mce.2012.10.005","volume":"373","author":"V Padmanabhan","year":"2013","unstructured":"Padmanabhan, V. & Veiga-Lopez, A. Sheep models of polycystic ovary syndrome phenotype. Mol. Cell. Endocrinol. 373, 8\u201320 (2013).","journal-title":"Mol. Cell. Endocrinol."},{"key":"78976_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mce.2013.01.013","volume":"373","author":"DH Abbott","year":"2013","unstructured":"Abbott, D. H. et al. Nonhuman primate models of polycystic ovary syndrome. Mol. Cell. Endocrinol. 373, 21\u201328 (2013).","journal-title":"Mol. Cell. Endocrinol."},{"key":"78976_CR11","first-page":"1328","volume":"79","author":"RB Barnes","year":"1994","unstructured":"Barnes, R. B., Rosenfield, R. L. & Ehrmann, D. A. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J. Clin. Endocrinol. Metab. 79, 1328 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"78976_CR12","doi-asserted-by":"publisher","first-page":"e24877","DOI":"10.1371\/journal.pone.0024877","volume":"6","author":"K Hogg","year":"2011","unstructured":"Hogg, K., Wood, C., McNeilly, A. S. & Duncan, W. C. The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS ONE 6, e24877 (2011).","journal-title":"PLoS ONE"},{"key":"78976_CR13","doi-asserted-by":"publisher","first-page":"20195","DOI":"10.1038\/s41598-019-56790-4","volume":"9","author":"KJ Siemienowicz","year":"2019","unstructured":"Siemienowicz, K. J. et al. Fetal androgen exposure is a determinant of adult male metabolic health. Sci. Rep. 9, 20195\u201320217 (2019).","journal-title":"Sci. Rep."},{"key":"78976_CR14","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/S0140-6736(05)66617-2","volume":"365","author":"SR Dalziel","year":"2005","unstructured":"Dalziel, S. R. et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 365, 1856\u20131862 (2005).","journal-title":"Lancet"},{"key":"78976_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1210\/er.2013-1012","volume":"34","author":"T Braun","year":"2013","unstructured":"Braun, T., Challis, J. R., Newnham, J. P. & Sloboda, D. M. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk. Endocr. Rev. 34, 885\u2013916 (2013).","journal-title":"Endocr. Rev."},{"key":"78976_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.rbmo.2019.10.009","volume":"40","author":"M Watters","year":"2019","unstructured":"Watters, M., Noble, M., Child, T. & Nelson, S. Short versus extended progesterone supplementation for luteal phase support in fresh IVF cycles: a systematic review and meta-analysis. Reprod. Biomed. Online 40, 143\u2013150 (2019).","journal-title":"Reprod. Biomed. Online"},{"key":"78976_CR17","first-page":"CD005943","volume":"8","author":"HA Wahabi","year":"2018","unstructured":"Wahabi, H. A., Fayed, A. A., Esmaeil, S. A. & Bahkali, K. H. Progestogen for treating threatened miscarriage. Cochrane Database Syst. Rev. 8, CD005943 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"78976_CR18","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1056\/NEJMoa1813730","volume":"380","author":"A Coomarasamy","year":"2019","unstructured":"Coomarasamy, A. et al. A randomized trial of progesterone in women with bleeding in early pregnancy. N. Engl. J. Med. 380, 1815\u20131824 (2019).","journal-title":"N. Engl. J. Med."},{"key":"78976_CR19","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1210\/en.2013-1279","volume":"154","author":"PA Fowler","year":"2013","unstructured":"Fowler, P. A. & O\u2019Shaughnessy, P. J. The goldilocks principle and developmental androgens in males, what is \u201cjust right\u201d?. Endocrinology 154, 1669\u20131671 (2013).","journal-title":"Endocrinology"},{"issue":"Suppl 4","key":"78976_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1439-0531.2012.02050.x","volume":"47","author":"M Bellingham","year":"2012","unstructured":"Bellingham, M. et al. Effects of exposure to environmental chemicals during pregnancy on the development of the male and female reproductive axes. Reprod. Domest. Anim. 47(Suppl 4), 15\u201322 (2012).","journal-title":"Reprod. Domest. Anim."},{"key":"78976_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/abbi.1997.0302","volume":"346","author":"H Yamazaki","year":"1997","unstructured":"Yamazaki, H. & Shimada, T. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch. Biochem. Biophys. 346, 161\u2013169 (1997).","journal-title":"Arch. Biochem. Biophys."},{"key":"78976_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/15513815.2017.1354411","volume":"36","author":"SK Quinney","year":"2017","unstructured":"Quinney, S. K., Benjamin, T., Zheng, X. & Patil, A. S. Characterization of maternal and fetal CYP3A-mediated progesterone metabolism. Fetal Pediatr. Pathol. 36, 400\u2013411 (2017).","journal-title":"Fetal Pediatr. Pathol."},{"key":"78976_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/03602532.2016.1188938","volume":"48","author":"M Murray","year":"2016","unstructured":"Murray, M. CYP2J2 - regulation, function and polymorphism. Drug. Metab. Rev. 48, 351\u2013368 (2016).","journal-title":"Drug. Metab. Rev."},{"key":"78976_CR24","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.3390\/ijms20174274","volume":"20","author":"YB Jarrar","year":"2019","unstructured":"Jarrar, Y. B. & Lee, S.-J. Molecular functionality of cytochrome P450 4 (CYP4) genetic polymorphisms and their clinical implications. Int. J. Mol. Sci. 20, 4274 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"78976_CR25","first-page":"163","volume":"49","author":"AN Brooks","year":"1995","unstructured":"Brooks, A. N., McNeilly, A. S. & Thomas, G. B. Role of GnRH in the ontogeny and regulation of the fetal hypothalamo-pituitary-gonadal axis in sheep. J. Reprod. Fertil. Suppl. 49, 163\u2013175 (1995).","journal-title":"J. Reprod. Fertil. Suppl."},{"key":"78976_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/bdrb.20089","volume":"77","author":"MS Golub","year":"2006","unstructured":"Golub, M. S., Kaufman, F. L., Campbell, M. A., Li, L.-H. & Donald, J. M. \u2018Natural\u2019 progesterone: information on fetal effects. Birth Defects Res. (Part B) 77, 455\u2013470 (2006).","journal-title":"Birth Defects Res. (Part B)"},{"key":"78976_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00737-013-0403-6","volume":"17","author":"SN Vigod","year":"2014","unstructured":"Vigod, S. N., Strasburg, K., Daskalakis, Z. J. & Blumberger, D. M. Systematic review of gamma-aminobutyric-acid inhibitory deficits across the reproductive life cycle. Arch. Womens Ment. Health 17, 87\u201395 (2014).","journal-title":"Arch. Womens Ment. Health"},{"key":"78976_CR28","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1210\/endo.139.8.6223","volume":"139","author":"CK Wagner","year":"1998","unstructured":"Wagner, C. K., Nakayama, A. Y. & De Vries, G. J. Potential role of maternal progesterone in the sexual differentiation of the brain. Endocrinology 139, 3658\u20133661 (1998).","journal-title":"Endocrinology"},{"key":"78976_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1677\/joe.0.1520379","volume":"152","author":"MB Nicol","year":"1997","unstructured":"Nicol, M. B., Hirst, J. J., Walker, D. & Thorburn, G. D. Effect of alteration of maternal plasma progesterone concentrations on fetal behavioural state during late gestation. J. Endocrinol. 152, 379\u2013386 (1997).","journal-title":"J. Endocrinol."},{"key":"78976_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1071\/R97074","volume":"9","author":"KJ Crossley","year":"1997","unstructured":"Crossley, K. J., Nicol, M. B., Hirst, J. J., Walker, D. W. & Thorburn, G. D. Suppression of arousal by progesterone in fetal sheep. Reprod. Fertil. Dev. 9, 767\u2013773 (1997).","journal-title":"Reprod. Fertil. Dev."},{"key":"78976_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4161\/spmg.1.3.18037","volume":"1","author":"JT Haverfield","year":"2011","unstructured":"Haverfield, J. T., Ham, S., Brown, K. A., Simpson, E. R. & Meachem, S. J. Teasing out the role of aromatase in the healthy and diseased testis. Spermatogenesis 1, 240\u2013249 (2011).","journal-title":"Spermatogenesis"},{"key":"78976_CR32","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/humrep\/dem091","volume":"22","author":"K Boukari","year":"2007","unstructured":"Boukari, K. et al. Human fetal testis: source of estrogen and target of estrogen action. Hum. Reprod. 22, 1885\u20131892 (2007).","journal-title":"Hum. Reprod."},{"key":"78976_CR33","first-page":"F873","volume":"261","author":"AS Brem","year":"1991","unstructured":"Brem, A. S., Matheson, K. L., Barnes, J. L. & Morris, D. J. 11-Dehydrocorticosterone, a glucocorticoid metabolite, inhibits aldosterone action in toad bladder. Am. J. Physiol. 261, F873\u2013F879 (1991).","journal-title":"Am. J. Physiol."},{"key":"78976_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1046\/j.1523-1755.1998.00033.x","volume":"54","author":"S Muto","year":"1998","unstructured":"Muto, S., Nemoto, J., Ebata, S., Kawakami, K. & Asano, Y. Corticosterone and 11-dehydrocorticosterone stimulate Na, K-ATPase gene expression in vascular smooth muscle cells. Kidney Int. 54, 492\u2013508 (1998).","journal-title":"Kidney Int."},{"key":"78976_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-018-1009-7","volume":"16","author":"ZC Johnston","year":"2018","unstructured":"Johnston, Z. C. et al. The human fetal adrenal produces cortisol but no detectable aldosterone throughout the second trimester. BMC Med. 16, 23\u201316 (2018).","journal-title":"BMC Med."},{"key":"78976_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1210\/endo.143.1.8583","volume":"143","author":"KE Sheppard","year":"2002","unstructured":"Sheppard, K. E. & Autelitano, D. J. 11Beta-hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorticosterone into transcriptionally active glucocorticoid in neonatal rat heart. Endocrinology 143, 198\u2013204 (2002).","journal-title":"Endocrinology"},{"key":"78976_CR37","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1210\/en.2013-1362","volume":"154","author":"E Harno","year":"2013","unstructured":"Harno, E. et al. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11\u03b2-HSD1 is knocked out in livers of male mice. Endocrinology 154, 3599\u20133609 (2013).","journal-title":"Endocrinology"},{"key":"78976_CR38","doi-asserted-by":"publisher","first-page":"e12066","DOI":"10.14814\/phy2.12066","volume":"2","author":"J McCartney","year":"2014","unstructured":"McCartney, J., Richards, E. M., Wood, C. E. & Keller-Wood, M. Mineralocorticoid effects in the late gestation ovine fetal lung. Physiol. Rep. 2, e12066 (2014).","journal-title":"Physiol. Rep."},{"key":"78976_CR39","doi-asserted-by":"publisher","first-page":"e38197","DOI":"10.1371\/journal.pone.0038197","volume":"7","author":"F Azibani","year":"2012","unstructured":"Azibani, F. et al. Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice. PLoS ONE 7, e38197 (2012).","journal-title":"PLoS ONE"},{"key":"78976_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pnpbp.2018.05.022","volume":"86","author":"M Davidovitch","year":"2018","unstructured":"Davidovitch, M. et al. Infertility treatments during pregnancy and the risk of autism spectrum disorder in the offspring. Prog. Neuropsychopharmacol. Biol. Psychiatry 86, 175\u2013179 (2018).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"78976_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/mp.2014.48","volume":"20","author":"S Baron-Cohen","year":"2015","unstructured":"Baron-Cohen, S. et al. Elevated fetal steroidogenic activity in autism. Mol. Psychiatry 20, 369\u2013376 (2015).","journal-title":"Mol. Psychiatry"},{"key":"78976_CR42","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1210\/en.2012-2153","volume":"154","author":"F Connolly","year":"2013","unstructured":"Connolly, F. et al. Excess androgens in utero alters fetal testis development. Endocrinology 154, 1921\u20131933 (2013).","journal-title":"Endocrinology"},{"key":"78976_CR43","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1210\/en.2008-0785","volume":"149","author":"SE Recabarren","year":"2008","unstructured":"Recabarren, S. E. et al. Prenatal testosterone excess reduces sperm count and motility. Endocrionology 149, 6444\u20136448 (2008).","journal-title":"Endocrionology"},{"key":"78976_CR44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1530\/rep.0.1250769","volume":"125","author":"RM Sharpe","year":"2003","unstructured":"Sharpe, R. M., McKinnell, C., Kivlin, C. & Fisher, J. S. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125, 769\u2013784 (2003).","journal-title":"Reproduction"},{"key":"78976_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fendo.2019.00224","volume":"10","author":"SB Meroni","year":"2019","unstructured":"Meroni, S. B. et al. Molecular mechanisms and signaling pathways involved in sertoli cell proliferation. Front. Endocrinol. 10, 224 (2019).","journal-title":"Front. Endocrinol."},{"key":"78976_CR46","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1159\/000125775","volume":"53","author":"SL Asa","year":"1991","unstructured":"Asa, S. L., Kovacs, K. & Singer, W. Human fetal adenohypophysis: morphologic and functional analysis in vitro. Neuroendocrinology 53, 562\u2013572 (1991).","journal-title":"Neuroendocrinology"},{"key":"78976_CR47","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1210\/jcem.85.6.6636","volume":"85","author":"J Gromoll","year":"2000","unstructured":"Gromoll, J., Eiholzer, U., Nieschlag, E. & Simoni, M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J. Clin. Endocrinol. Metab. 85, 2281\u20132286 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"78976_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000363609","volume":"27","author":"M Welsh","year":"2014","unstructured":"Welsh, M., Suzuki, H. & Yamada, G. The masculinization programming window. Endocr. Dev. 27, 17\u201327 (2014).","journal-title":"Endocr. Dev."},{"key":"78976_CR49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archpedi.159.10.957","volume":"159","author":"SL Carmichael","year":"2005","unstructured":"Carmichael, S. L. et al. Maternal progestin intake and risk of hypospadias. Arch. Pediatr. Adolesc. Med. 159, 957\u2013962 (2005).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"78976_CR50","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","volume":"373","author":"A Coomarasamy","year":"2015","unstructured":"Coomarasamy, A. et al. A randomized trial of progesterone in women with recurrent miscarriages. N. Engl. J. Med. 373, 2141\u20132148 (2015).","journal-title":"N. Engl. J. Med."},{"key":"78976_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000242005","volume":"45","author":"G Pointis","year":"1984","unstructured":"Pointis, G., Latreille, M. T., Richard, M. O., D\u2019Athis, P. & Cedard, L. Effect of maternal progesterone exposure on fetal testosterone in mice. Biol. Neonate 45, 203\u2013208 (1984).","journal-title":"Biol. Neonate"},{"key":"78976_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000457768","volume":"10","author":"G Pointis","year":"1987","unstructured":"Pointis, G., Latreille, M. T., Richard, M. O., D\u2019Athis, P. D. & Cedard, L. Effect of natural progesterone treatment during pregnancy on fetal testosterone and sexual behavior of the male offspring in the mouse. Dev. Pharmacol. Ther. 10, 385\u2013392 (1987).","journal-title":"Dev. Pharmacol. Ther."},{"key":"78976_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1471-0528.1984.tb05896.x","volume":"91","author":"RG Farquharson","year":"1984","unstructured":"Farquharson, R. G. & Klopper, A. I. Progesterone concentrations in maternal and fetal blood. BJOG 91, 133\u2013137 (1984).","journal-title":"BJOG"},{"key":"78976_CR54","doi-asserted-by":"publisher","first-page":"e3000002","DOI":"10.1371\/journal.pbio.3000002","volume":"17","author":"PJ O'Shaughnessy","year":"2019","unstructured":"O\u2019Shaughnessy, P. J. et al. Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol 17, e3000002 (2019).","journal-title":"PLoS Biol"},{"key":"78976_CR55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1210\/jcem-44-5-934","volume":"44","author":"GL Warne","year":"1977","unstructured":"Warne, G. L., Faiman, C., Reyes, F. I. & Winter, J. S. Studies on human sexual development. V. Concentrations of testosterone, 17-hydroxyprogesterone and progesterone in human amniotic fluid throughout gestation. J. Clin. Endocrinol. Metab. 44, 934\u2013938 (1977).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"78976_CR56","doi-asserted-by":"publisher","first-page":"27408","DOI":"10.1038\/srep27408","volume":"6","author":"S Ramaswamy","year":"2016","unstructured":"Ramaswamy, S. et al. Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet \u03b1\/\u03b2 cell ratio and subsequent insulin secretion. Sci. Rep. 6, 27408 (2016).","journal-title":"Sci. Rep."},{"key":"78976_CR57","doi-asserted-by":"publisher","first-page":"e111280","DOI":"10.1371\/journal.pone.0111280","volume":"9","author":"F Connolly","year":"2014","unstructured":"Connolly, F. et al. The local effects of ovarian diathermy in an ovine model of polycystic ovary syndrome. PLoS ONE 9, e111280 (2014).","journal-title":"PLoS ONE"},{"key":"78976_CR58","doi-asserted-by":"publisher","first-page":"104432","DOI":"10.1016\/j.psyneuen.2019.104432","volume":"111","author":"RM Gifford","year":"2019","unstructured":"Gifford, R. M. et al. Positive adaptation of HPA axis function in women during 44 weeks of infantry-based military training. Psychoneuroendocrinology 111, 104432 (2019).","journal-title":"Psychoneuroendocrinology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78976-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78976-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78976-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:41:34Z","timestamp":1670373694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78976-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78976"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78976-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21920"}}